Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Medical Malpractice Law & StrategyLJN NewslettersNewsSections

Movers & Shakers

By ALM Staff | Law Journal Newsletters |
September 29, 2008

Ungaretti & Harris (Chicago): Steven F. Banghart has joined the firm's health care department as partner in the Chicago office. Banghart will focus on representing health care providers. Previously, Banghart was a partner at Katten Muchin Rosenman.

GlaxoSmithKline (Philadelphia): Sidley Austin partner Dan Troy joins pharmaceuticals giant GlaxoSmithKline as senior vice president and general counsel in the London-based company's Philadelphia office. While at Sidley Austin, Troy was a partner in the firm's life sciences practice and appellate litigation groups, advising pharmaceutical companies and trade associations on FDA and other regulatory matters. Troy is also former chief counsel of the U.S. Food and Drug Administration.

Parker McCay (Marlton, NJ): Parker McCay has promoted counsel Lora Foley to partner. Foley concentrates on medical malpractice, insurance defense and commercial litigation.

Arnold & Porter (New York): Arnold & Porter has added two attorneys to its health care regulatory team: Jeffrey Ruggiero joins as partner and Andrew Bogen joins as counsel. They were previously with Arent Fox. In the firm's Washington office: Vernessa Pollard, former associate chief counsel in the U.S. Food and Drug Administration's Office of Chief Counsel, has as a counsel in the firm's FDA and health care practice.

Sedgwick, Detert, Moran & Arnold (San Francisco): Linda A. Willett has joined firm's drug and medical-device practice as partner in the San Francisco-based firm's New York office. Willett will focus on complex litigation. Previously, she was vice president and deputy general counsel at Bristol-Myers Squibb Co.

Ungaretti & Harris (Chicago): Steven F. Banghart has joined the firm's health care department as partner in the Chicago office. Banghart will focus on representing health care providers. Previously, Banghart was a partner at Katten Muchin Rosenman.

GlaxoSmithKline (Philadelphia): Sidley Austin partner Dan Troy joins pharmaceuticals giant GlaxoSmithKline as senior vice president and general counsel in the London-based company's Philadelphia office. While at Sidley Austin, Troy was a partner in the firm's life sciences practice and appellate litigation groups, advising pharmaceutical companies and trade associations on FDA and other regulatory matters. Troy is also former chief counsel of the U.S. Food and Drug Administration.

Parker McCay (Marlton, NJ): Parker McCay has promoted counsel Lora Foley to partner. Foley concentrates on medical malpractice, insurance defense and commercial litigation.

Arnold & Porter (New York): Arnold & Porter has added two attorneys to its health care regulatory team: Jeffrey Ruggiero joins as partner and Andrew Bogen joins as counsel. They were previously with Arent Fox. In the firm's Washington office: Vernessa Pollard, former associate chief counsel in the U.S. Food and Drug Administration's Office of Chief Counsel, has as a counsel in the firm's FDA and health care practice.

Sedgwick, Detert, Moran & Arnold (San Francisco): Linda A. Willett has joined firm's drug and medical-device practice as partner in the San Francisco-based firm's New York office. Willett will focus on complex litigation. Previously, she was vice president and deputy general counsel at Bristol-Myers Squibb Co.

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
Major Differences In UK, U.S. Copyright Laws Image

This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.

The Article 8 Opt In Image

The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.

Strategy vs. Tactics: Two Sides of a Difficult Coin Image

With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.

Legal Possession: What Does It Mean? Image

Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.

The Stranger to the Deed Rule Image

In 1987, a unanimous Court of Appeals reaffirmed the vitality of the "stranger to the deed" rule, which holds that if a grantor executes a deed to a grantee purporting to create an easement in a third party, the easement is invalid. Daniello v. Wagner, decided by the Second Department on November 29th, makes it clear that not all grantors (or their lawyers) have received the Court of Appeals' message, suggesting that the rule needs re-examination.